SHI Menglong 1,2,3 , CAO Lujia 1,2,3 , WANG Hui 1,2,3 , LIU Chunxiang 1,2,3 , PANG Bo 1,2,3 , PANG Wentai 1,2,3 , ZHENG Wenke 1,2,3 , YANG Fengwen 1,2,3 , ZHANG Junhua 1,2,3
  • 1. Evidence-Based Medicine Center, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
  • 2. Haihe Laboratory of Modern Traditional Chinese Medicine, Tianjin 301617, P. R. China;
  • 3. NMPA Key Laboratory for Evidence-based Evaluation of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
ZHANG Junhua, Email: zhtcm@foxmail.com
Export PDF Favorites Scan Get Citation

The current disease-centered efficacy evaluation index system is mostly target-oriented and guided by objective indicators. Direct application of such a system may lead to discrepancies between evaluation outcomes and patients’ clinical needs, as well as difficulties in fully demonstrating the clinical advantages of medical products. To address this issue, the U.S. Food and Drug Administration (FDA) issued the patient-focused drug development (PFDD) guidance principles and proposed the concept of patient-centered clinical efficacy evaluation, emphasizing the development of clinical outcome assessment (COA) tools that are oriented to patients’ clinical needs, can reflect the clinical advantages of medical products, and clarify their clinical positioning. Among these principles, PFDD Guidance 3 elaborates on the concept and development methodology of COA. This document was updated in 2025 and finalized as an official version. Based on this final document, this paper summarizes the key elements and development process of COA, sorts out the critical steps and technical essentials in COA development, and discusses the value, significance and application prospects of COA in traditional Chinese medicine (TCM), aiming to provide references for domestic COA development.

Citation: SHI Menglong, CAO Lujia, WANG Hui, LIU Chunxiang, PANG Bo, PANG Wentai, ZHENG Wenke, YANG Fengwen, ZHANG Junhua. An analysis and reflection on the key updates to the patient-focused clinical outcome assessment. Chinese Journal of Evidence-Based Medicine, 2026, 26(10): 1233-1240. doi: 10.7507/1672-2531.202601220 Copy

Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    The STROCSS guideline for reporting observational studies in surgery: a discussion on methodological application and academic value